Treosulfan-Based Conditioning Regimen for Second Allograft in Patients with Myelofibrosis

SIMPLE SUMMARY: Currently, the only curative therapy in myelofibrosis is allogeneic hematopoietic stem cell transplantation. Donor lymphocyte infusion and second stem cell transplantation are the two main treatment options for myelofibrosis patients who relapse after the first transplantation. The o...

Descripción completa

Detalles Bibliográficos
Autores principales: Atagunduz, Isik Kaygusuz, Klyuchnikov, Evgeny, Wolschke, Christine, Janson, Dietlinde, Heidenreich, Silke, Christopeit, Maximilian, Ayuk, Francis, Kröger, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690833/
https://www.ncbi.nlm.nih.gov/pubmed/33114179
http://dx.doi.org/10.3390/cancers12113098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690833/
https://www.ncbi.nlm.nih.gov/pubmed/33114179
http://dx.doi.org/10.3390/cancers12113098

Ejemplares similares